Page last updated: 2024-09-03

lestaurtinib and bicalutamide

lestaurtinib has been researched along with bicalutamide in 1 studies

Compound Research Comparison

Studies
(lestaurtinib)
Trials
(lestaurtinib)
Recent Studies (post-2010)
(lestaurtinib)
Studies
(bicalutamide)
Trials
(bicalutamide)
Recent Studies (post-2010) (bicalutamide)
12412631,313212541

Protein Interaction Comparison

ProteinTaxonomylestaurtinib (IC50)bicalutamide (IC50)
Progesterone receptorOryctolagus cuniculus (rabbit)5.6
Progesterone receptorHomo sapiens (human)1.819
Androgen receptorHomo sapiens (human)0.404
Androgen receptorRattus norvegicus (Norway rat)0.7168
Androgen receptorMus musculus (house mouse)1.835
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)0.12
Progesterone receptorRattus norvegicus (Norway rat)0.89

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bologna, M; Festuccia, C; Gravina, GL; Muzi, P; Pomante, R; Ricevuto, E; Ventura, L; Vicentini, C1

Other Studies

1 other study(ies) available for lestaurtinib and bicalutamide

ArticleYear
In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
    The Prostate, 2007, Sep-01, Volume: 67, Issue:12

    Topics: Adult; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Blotting, Western; Carbazoles; Carcinoma; Cell Line, Tumor; Cohort Studies; Dihydrotestosterone; Furans; Humans; Immunohistochemistry; Indoles; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Protein Kinase Inhibitors; Receptor, Nerve Growth Factor; Receptor, trkA; Receptor, trkC; Tosyl Compounds

2007